why does nobody talk about thymosin
why does nobody talk about thymosin. I would rather ask a basic question now than get this wrong quietly for two months. Naming in this space is inconsistent. Several widely used names map to more than one molecule, so a catalogue number and a sequence beat a common name every time. Purity methods differ by compound…
Stocked line or made to order — did they say?
The three questions to ask before ordering anything from the long tail of a catalogue.
What exactly is it — catalogue number or sequence, not a common name, because several common names map to more than one molecule. How was identity established — mass against theoretical, ideally, rather than a bare purity figure. What are the storage conditions, stated specifically, with a state and a duration attached.
Then two commercial questions that save time: is this a stocked line or made to order, and what is the lead time in writing. All five are one email, and the shape of the reply tells you a great deal before any material moves.
net peptide content is where the surprises live
the less-tested the compound, the more the identity test matters
the less-tested the compound, the more the identity test matters
This is the rule for anything unusual. Identity before anything else.
Asked for a catalogue number rather than removing. Common names are ambiguous here and it makes threads unusable later.
a secretagogue and a fragment are not the same class of thing